Clinical pharmacokinetic and in vitro combination studies of nolatrexed dihydrochloride (AG337, Thymitaq(TM)) and paclitaxel

類似資料

• A phase I study of the lipophilic thymidylate synthase inhibitor Thymitaq™ (nolatrexed dihydrochloride) given by 10-day oral administration
  著者:: Jodrell, D I, 等
  出版事項: (1999)
• A phase I study of nolatrexed dihydrochloride in children with advanced cancer. A United Kingdom Children's Cancer Study Group Investigation
  著者:: Estlin, E J, 等
  出版事項: (2001)
• A clinical and pharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancer.
  著者:: Siddiqui, N., 等
  出版事項: (1997)
• Pharmacokinetics of cefepime dihydrochloride arginine in subjects with renal impairment.
  著者:: Cronqvist, J, 等
  出版事項: (1992)
• The relationship between intrinsic thymidylate synthase expression and sensitivity to THYMITAQ in human leukaemia and colorectal carcinoma cell lines.
  著者:: Estlin, E. J., 等
  出版事項: (1997)